AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 22773237 — intervention group
Group type: EXPERIMENTAL
Intervention: V‐shaped liver suspension technique (V‐LIST)
Number of subjects: 60
Study 22586903 — intervention group
Group type: EXPERIMENTAL
Intervention: cycloferon (10 days, intramuscularly or orally depending on age)
Number of subjects: 80
Study 22586903 — intervention group
Group type: COMPARATOR
Intervention: standard therapy alone
Number of subjects: 80
Study 19581567 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (dosing range, 1200-2400 mg/d)
Number of subjects: 50
Study 19581567 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 17337726 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioabsorbable arrows
Number of subjects: 100
Study 17337726 — intervention group
Group type: COMPARATOR
Intervention: Inside-out suturing
Number of subjects: 100
Study 16339336 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E supplementation for 1 year
Number of subjects: 617
Study 16339336 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 617
Study 11994337 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.27 mg/kg.wk of recombinant human GH with low dose ethinyl E2
Number of subjects: 232
Study 11994337 — intervention group
Group type: COMPARATOR
Intervention: 0.27 mg/kg.wk of recombinant human GH with oral placebo
Number of subjects: 232
Study 11994337 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.36 mg/kg.wk of recombinant human GH with low dose ethinyl E2
Number of subjects: 232
Study 11994337 — intervention group
Group type: COMPARATOR
Intervention: 0.36 mg/kg.wk of recombinant human GH with oral placebo
Number of subjects: 232
Study 11994337 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth hormone treatment
Number of subjects: 232
Study 11994337 — intervention group
Group type: EXPERIMENTAL
Intervention: Early administration of estrogen (low doses)
Number of subjects: 232
Study 9806584 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic ovarian transposition
Number of subjects: 24
Study 7702820 — intervention group
Group type: EXPERIMENTAL
Intervention: Polymyxin B‐neomycin‐hydrocortisone drops (single dose intraoperatively)
Number of subjects: 300
Study 7702820 — intervention group
Group type: EXPERIMENTAL
Intervention: Polymyxin B‐neomycin‐hydrocortisone drops (5-day course after intraoperative dose)
Number of subjects: 300
Study 7702820 — intervention group
Group type: COMPARATOR
Intervention: No antibiotic drops (control group)
Number of subjects: 300
Study 2792168 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 9
Study 2792168 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 356524 — intervention group
Group type: EXPERIMENTAL
Intervention: BCNU
Number of subjects: 102
Study 356524 — intervention group
Group type: COMPARATOR
Intervention: CCNU
Number of subjects: 102
Study 30217770 — intervention group
Group type: EXPERIMENTAL
Intervention: Micronutrient treatment
Number of subjects: 71
Study 30217770 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 71
Study 29266450 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified 8-week reminiscence therapy (Group 1: 25 couples, Group 2: 22 couples)
Number of subjects: 75
Study 29266450 — intervention group
Group type: COMPARATOR
Intervention: Waiting list (control group, Group 3: 28 couples)
Number of subjects: 75
Study 27170530 — intervention group
Group type: EXPERIMENTAL
Intervention: Condensed regimen (100 mg twice daily for 2 weeks followed by 200 mg twice daily)
Number of subjects: 498
Study 27170530 — intervention group
Group type: COMPARATOR
Intervention: Conservative regimen (50 mg twice daily for 2 weeks, 100 mg twice daily for 3 weeks, followed by 200 mg twice daily)
Number of subjects: 498
Study 27170530 — intervention group
Group type: EXPERIMENTAL
Intervention: Condensed regimen
Number of subjects: 498
Study 27170530 — intervention group
Group type: COMPARATOR
Intervention: Conservative regimen
Number of subjects: 498
Study 27170530 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall treatment
Number of subjects: 498
Study 27170530 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose ACEI/ARB with condensed regimen
Number of subjects: 498
Study 27170530 — intervention group
Group type: COMPARATOR
Intervention: High-dose ACEI/ARB with conservative regimen
Number of subjects: 498
Study 27170530 — intervention group
Group type: COMPARATOR
Intervention: Low-dose ACEI/ARB with conservative regimen
Number of subjects: 498
Study 27170530 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose ACEI/ARB with condensed regimen
Number of subjects: 498
Study 25404439 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual Vacuum Aspiration (MVA) as outpatient procedure
Number of subjects: 177
Study 25404439 — intervention group
Group type: COMPARATOR
Intervention: Manual Vacuum Aspiration (MVA) as inpatient procedure
Number of subjects: 177
Study 22813494 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil infusion maintained at a target effect site concentration of 1.0 ng/ml during ventilator weaning
Number of subjects: 50
Study 22813494 — intervention group
Group type: COMPARATOR
Intervention: Control group with propofol infusion stopped and remifentanil infusion also stopped during ventilator weaning
Number of subjects: 50
Study 20571327 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifactor approach (cognitive‐behavioral therapies, diet and physical activity counselling, 'on‐off' prescription of orlistat)
Number of subjects: 50
Study 20571327 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifactor approach
Number of subjects: 50
Study 17270617 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized urodynamic testing procedures protocol
Number of subjects: 20
Study 17270617 — intervention group
Group type: EXPERIMENTAL
Intervention: UDS Interpretation Guidelines
Number of subjects: 20
Study 15927733 — intervention group
Group type: EXPERIMENTAL
Intervention: Head rotation during whiplash-type impacts
Number of subjects: 0
Study 15927733 — intervention group
Group type: EXPERIMENTAL
Intervention: Trunk flexion during whiplash-type impacts
Number of subjects: 0
Study 15927733 — intervention group
Group type: EXPERIMENTAL
Intervention: Head rotation or trunk flexion at the time of impact
Number of subjects: 0
Study 12099782 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous morphine
Number of subjects: 0
Study 12099782 — intervention group
Group type: COMPARATOR
Intervention: Oral pizotifen
Number of subjects: 0
Study 12099782 — intervention group
Group type: COMPARATOR
Intervention: Intravenous atropine or physostigmine
Number of subjects: 0
Study 12099782 — intervention group
Group type: COMPARATOR
Intervention: Oral L-dopa, bromocriptine or haloperidol
Number of subjects: 0
Study 10072229 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 80
Study 10072229 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 7586937 — intervention group
Group type: EXPERIMENTAL
Intervention: Moclobemide (400 mg/day for 2 months, then 200 mg/day for 1 month)
Number of subjects: 88
Study 7586937 — intervention group
Group type: EXPERIMENTAL
Intervention: Moclobemide
Number of subjects: 88
Study 7586937 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 88
Study 2180817 — intervention group
Group type: EXPERIMENTAL
Intervention: Furosemide 40 mg
Number of subjects: 18
Study 2180817 — intervention group
Group type: EXPERIMENTAL
Intervention: Low sodium diet for 3 days
Number of subjects: 18
Study 2180817 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol 100 mg
Number of subjects: 18
Study 2180817 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 18
Study 207295 — intervention group
Group type: EXPERIMENTAL
Intervention: salbutamol infusion (0.15 microgram kg‐1 min‐1 for 60 min)
Number of subjects: 4
Study 207295 — intervention group
Group type: EXPERIMENTAL
Intervention: practolol injection (2 mg kg‐1 for 10 min); salbutamol infusion
Number of subjects: 4
Study 207295 — intervention group
Group type: COMPARATOR
Intervention: saline injection; saline infusion
Number of subjects: 4
Study 207295 — intervention group
Group type: EXPERIMENTAL
Intervention: propranolol injection (0.3 mg kg‐1 for 10 min); salbutamol infusion
Number of subjects: 4
Study 30239799 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-TNF-alpha therapy during pregnancy
Number of subjects: 72
Study 28704419 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy diet rich in unsaturated fat (4-week dietary intervention)
Number of subjects: 11
Study 28704419 — intervention group
Group type: COMPARATOR
Intervention: Usual diet (control diet)
Number of subjects: 11
Study 26112329 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone suppression test
Number of subjects: 24
Study 26112329 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal early morning cortisol and dehydroepiandrosterone sulfate
Number of subjects: 24
Study 25276717 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure applied to the P6 acupoint using special Acubands
Number of subjects: 88
Study 25276717 — intervention group
Group type: COMPARATOR
Intervention: Control group with Acubands fastened loosely on wrists
Number of subjects: 88
Study 20500802 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebrolysin 10 ml
Number of subjects: 133
Study 20500802 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebrolysin 30 ml
Number of subjects: 133
Study 20500802 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebrolysin 60 ml
Number of subjects: 133
Study 20500802 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 133
Study 19427123 — intervention group
Group type: EXPERIMENTAL
Intervention: EMLA cream (local anaesthetic)
Number of subjects: 39
Study 19427123 — intervention group
Group type: COMPARATOR
Intervention: Sorbolene treatment
Number of subjects: 39
Study 16949521 — intervention group
Group type: EXPERIMENTAL
Intervention: Protease inhibitory modulating matrix (the OCR/collagen Promogran matrix, Ethicon) with dressings changed daily
Number of subjects: 33
Study 16949521 — intervention group
Group type: COMPARATOR
Intervention: Good standard wound care
Number of subjects: 33
Study 15181135 — intervention group
Group type: EXPERIMENTAL
Intervention: PET (Positron Emission Tomography)
Number of subjects: 32
Study 11509468 — intervention group
Group type: EXPERIMENTAL
Intervention: DASH diet (n=23)
Number of subjects: 72
Study 11509468 — intervention group
Group type: COMPARATOR
Intervention: Control diet (n=25)
Number of subjects: 72
Study 11509468 — intervention group
Group type: COMPARATOR
Intervention: Fruits/vegetables diet (n=24)
Number of subjects: 72
Study 9114771 — intervention group
Group type: EXPERIMENTAL
Intervention: Cilostazol
Number of subjects: 68
Study 9114771 — intervention group
Group type: COMPARATOR
Intervention: Aspirin or Ticlopidine (Control)
Number of subjects: 68
Study 8513847 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin pretreatment (7-day course)
Number of subjects: 12
Study 8513847 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 12
Study 3552176 — intervention group
Group type: EXPERIMENTAL
Intervention: Cephalothin prophylaxis (25 mg/kg, four doses)
Number of subjects: 63
Study 3552176 — intervention group
Group type: COMPARATOR
Intervention: Placebo (multivitamin)
Number of subjects: 63
Study 31696644 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 pulses of 5-Hz rTMS
Number of subjects: 15
Study 31696644 — intervention group
Group type: EXPERIMENTAL
Intervention: 1200 pulses of 5-Hz rTMS
Number of subjects: 15
Study 31696644 — intervention group
Group type: COMPARATOR
Intervention: Baseline
Number of subjects: 15
Study 28832909 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-layer unlocked sutures
Number of subjects: 435
Study 28832909 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-layer locked sutures
Number of subjects: 435
Study 28832909 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-layer sutures
Number of subjects: 435
Study 25442225 — intervention group
Group type: EXPERIMENTAL
Intervention: Individually tailored, culturally and linguistically adapted physical activity intervention
Number of subjects: 266
Study 25442225 — intervention group
Group type: COMPARATOR
Intervention: Wellness contact control
Number of subjects: 266
Study 23269413 — intervention group
Group type: EXPERIMENTAL
Intervention: Abnormal MRI findings (ANE)
Number of subjects: 36
Study 23269413 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal conventional MRI findings (NNE)
Number of subjects: 36
Study 23269413 — intervention group
Group type: COMPARATOR
Intervention: Control group (term-equivalent premature neonates)
Number of subjects: 36
Study 21992502 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise therapy in addition to GP care
Number of subjects: 210
Study 21992502 — intervention group
Group type: COMPARATOR
Intervention: GP care alone
Number of subjects: 210
Study 18492523 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 85
Study 18492523 — intervention group
Group type: COMPARATOR
Intervention: Goal setting alone
Number of subjects: 85
Study 18492523 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin adherence with lifestyle change
Number of subjects: 85
Study 16801657 — intervention group
Group type: EXPERIMENTAL
Intervention: Perfusion MRI
Number of subjects: 79
Study 16801657 — intervention group
Group type: EXPERIMENTAL
Intervention: Perfusion MRI with CBF threshold value of 1.2
Number of subjects: 79
Study 16801657 — intervention group
Group type: EXPERIMENTAL
Intervention: Perfusion MRI with CBF threshold value of 0.5
Number of subjects: 79
Study 16801657 — intervention group
Group type: EXPERIMENTAL
Intervention: Perfusion MRI with CBF threshold value of 1.4
Number of subjects: 79
Study 16801657 — intervention group
Group type: EXPERIMENTAL
Intervention: Perfusion MRI with CBF threshold value of 1.6
Number of subjects: 79
Study 15539017 — intervention group
Group type: EXPERIMENTAL
Intervention: Shengxueling Granule (SXLG)
Number of subjects: 86
Study 15539017 — intervention group
Group type: COMPARATOR
Intervention: Prednisone (control)
Number of subjects: 86
Study 11063063 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV-positive speakers in a multicomponent intervention
Number of subjects: 1491
Study 11063063 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of intervention and speakers
Number of subjects: 1491
Study 11063063 — intervention group
Group type: COMPARATOR
Intervention: Knowledge-based curriculum (comparison condition)
Number of subjects: 1491
Study 9408812 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (5 mg plus 20 mg sustained release)
Number of subjects: 24
Study 9408812 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 8111512 — intervention group
Group type: EXPERIMENTAL
Intervention: Clarithromycin (500 mg twice daily)
Number of subjects: 142
Study 8111512 — intervention group
Group type: COMPARATOR
Intervention: Amoxicillin (500 mg three times daily)
Number of subjects: 142
Study 2874782 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracapsular extraction plus contact lens (Group A)
Number of subjects: 333
Study 2874782 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracapsular extraction plus Federov implant (Group B)
Number of subjects: 333
Study 2874782 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracapsular extraction plus iridocapsular implant (Group C)
Number of subjects: 333
Study 29633166 — intervention group
Group type: EXPERIMENTAL
Intervention: Vilazodone 15 mg/day
Number of subjects: 529
Study 29633166 — intervention group
Group type: EXPERIMENTAL
Intervention: Vilazodone 30 mg/day
Number of subjects: 529
Study 29633166 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 529
Study 27449253 — intervention group
Group type: EXPERIMENTAL
Intervention: Trauma-focused treatment (TF treatment) including Prolonged Exposure and Eye Movement Desensitization and Reprocessing therapy, 8 sessions
Number of subjects: 108
Study 24275780 — intervention group
Group type: EXPERIMENTAL
Intervention: Septoplasty
Number of subjects: 72
Study 22188037 — intervention group
Group type: EXPERIMENTAL
Intervention: Venowave device
Number of subjects: 150
Study 22188037 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care with graduated compression stockings and physiotherapy)
Number of subjects: 150
Study 22188037 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 150
Study 20537515 — intervention group
Group type: EXPERIMENTAL
Intervention: Crocetin
Number of subjects: 21
Study 20537515 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 18543502 — intervention group
Group type: EXPERIMENTAL
Intervention: Lecture on air embolism
Number of subjects: 52
Study 18543502 — intervention group
Group type: COMPARATOR
Intervention: Problem-based learning class
Number of subjects: 52
Study 15954970 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetyl cysteine (NAC) infusion, 5 mg kg(‐1).h(‐1)
Number of subjects: 30
Study 15954970 — intervention group
Group type: COMPARATOR
Intervention: Saline infusion (Control)
Number of subjects: 30
Study 12070950 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous fluid at 100% of normal maintenance volumes (half‐normal saline and 5% dextrose)
Number of subjects: 346
Study 12070950 — intervention group
Group type: COMPARATOR
Intervention: Oral fluid restriction at 60% of normal maintenance volumes (breast milk by nasogastric tube)
Number of subjects: 346
Study 12070950 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous fluid at 100% of normal maintenance volumes
Number of subjects: 346
Study 12070950 — intervention group
Group type: COMPARATOR
Intervention: Oral fluid restriction at 60% of normal maintenance volumes
Number of subjects: 346
Study 12070950 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 346
Study 11408131 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin-surface-modified poly(methyl methacrylate) (PMMA) IOL
Number of subjects: 31
Study 11408131 — intervention group
Group type: COMPARATOR
Intervention: Soft hydrophobic acrylic IOL
Number of subjects: 31
Study 9230719 — intervention group
Group type: EXPERIMENTAL
Intervention: SR27417A
Number of subjects: 12
Study 9230719 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 8130497 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerized, telephone-based stress management program
Number of subjects: 0
Study 8130497 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 0
Study 3671255 — intervention group
Group type: EXPERIMENTAL
Intervention: Xylose tolerance test at 3100 m and 4846 m
Number of subjects: 11
Study 3671255 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxalate loading test
Number of subjects: 11
Study 3671255 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct fat absorption test with 100 g fat
Number of subjects: 11
Study 29059289 — intervention group
Group type: EXPERIMENTAL
Intervention: Bonded retainers (BRs)
Number of subjects: 60
Study 29059289 — intervention group
Group type: COMPARATOR
Intervention: Vacuum‐formed retainers (VFRs)
Number of subjects: 60
Study 27898154 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based intervention for families of Veterans with PTSD
Number of subjects: 103
Study 27898154 — intervention group
Group type: COMPARATOR
Intervention: Control group with no intervention
Number of subjects: 103
Study 25091871 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive PPD screening and management program
Number of subjects: 2343
Study 25091871 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 2343
Study 22952008 — intervention group
Group type: EXPERIMENTAL
Intervention: 311 nm UVB phototherapy
Number of subjects: 23
Study 22952008 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 23
Study 22952008 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall PLE patients (both treated and untreated)
Number of subjects: 23
Study 20683336 — intervention group
Group type: EXPERIMENTAL
Intervention: Monthly Personal Digital Assistant supported home assessments by PLWAs with clinic appointments every 3 months
Number of subjects: 100
Study 20683336 — intervention group
Group type: COMPARATOR
Intervention: Standard of care monthly clinic visits
Number of subjects: 100
Study 18460033 — intervention group
Group type: EXPERIMENTAL
Intervention: darunavir 400 mg bid plus ketoconazole 200 mg bid
Number of subjects: 0
Study 18460033 — intervention group
Group type: EXPERIMENTAL
Intervention: darunavir/ritonavir 400/100 mg bid plus ketoconazole 200 mg bid
Number of subjects: 0
Study 18460033 — intervention group
Group type: EXPERIMENTAL
Intervention: ketoconazole 200 mg bid with darunavir/ritonavir
Number of subjects: 0
Study 15860682 — intervention group
Group type: EXPERIMENTAL
Intervention: Added dead space (400 ml)
Number of subjects: 2
Study 15860682 — intervention group
Group type: EXPERIMENTAL
Intervention: Added dead space (400 ml) and 38% O2
Number of subjects: 2
Study 15860682 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 2
Study 12970302 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained release melatonin (1.5 mg)
Number of subjects: 8
Study 12970302 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 10619732 — intervention group
Group type: EXPERIMENTAL
Intervention: Amphotericin B with or without flucytosine
Number of subjects: 0
Study 10619732 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 9289453 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregnancy complicated by hypertension (studied group)
Number of subjects: 62
Study 9289453 — intervention group
Group type: COMPARATOR
Intervention: Healthy pregnant women (control group)
Number of subjects: 62
Study 1999091 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrioventricular pacing (atrial demand, atrioventricular sequential, atrioventricular universal)
Number of subjects: 40
Study 1999091 — intervention group
Group type: COMPARATOR
Intervention: Ventricular demand pacing
Number of subjects: 40
Study 1999091 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrioventricular pacing
Number of subjects: 40
Study 31997369 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy (MBCT)
Number of subjects: 68
Study 31997369 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral analysis system of psychotherapy (CBASP)
Number of subjects: 68